{"schema_version":"1","generated_at":"2026-11-04T00:17:11.079Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ritu-salani","json_url":"https://www.findmykol.com/kol/ritu-salani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ritu-salani","name":"Ritu Salani","credential":"MD","specialty":"Obstetrics & Gynecology","specialty_raw":"Obstetrics & Gynecology","therapeutic_area":"Gynecologic","therapeutic_areas":["Gynecologic"],"institution":"University of California, Los Angeles","institution_url":"https://www.findmykol.com/institution/university-of-california-los-angeles","city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1356482905","orcid":"0000-0002-8907-0966","openalex":"A5009863325"},"summary":"Ritu Salani is a Gynecologic physician affiliated with University of California, Los Angeles. OpenAlex indexes 316 publications with 8,807 citations (h-index 45); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Obstetrics & Gynecology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Gynecologic"]},"scholarship":{"works_count":316,"cited_by_count":8807,"h_index":45,"latest_activity_year":2025,"citation_standing":{"top_percent":5,"cohort":"Obstetrics & Gynecology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06099418","title":"Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Nykode Therapeutics ASA","source_url":"https://clinicaltrials.gov/study/NCT06099418","trial_url":"https://www.findmykol.com/trial/NCT06099418"},{"nct":"NCT01281852","title":"Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT01281852","trial_url":"https://www.findmykol.com/trial/NCT01281852"},{"nct":"NCT01219777","title":"Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \\Bevacizumab for Primary Ovarian","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Ritu Salani","source_url":"https://clinicaltrials.gov/study/NCT01219777","trial_url":"https://www.findmykol.com/trial/NCT01219777"}],"source":"trials"},"payments":{"company_count":20,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1356482905","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2025.0038","status":"verified"},{"title":"Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","year":2024,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2024.0013","status":"verified"},{"title":"Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","year":2023,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2023.0006","status":"verified"},{"title":"NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024","year":2023,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2023.0062","status":"verified"},{"title":"The increasing incidence of stage IV cervical cancer in the USA: what factors are related?","year":2022,"journal":"International Journal of Gynecological Cancer","source_url":"https://doi.org/10.1136/ijgc-2022-003728","status":"verified"}],"source":"works"},"similar":[{"name":"Dennis Slamon","slug":"dennis-slamon","institution":"University of California, Los Angeles","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/dennis-slamon","json_url":"https://www.findmykol.com/kol/dennis-slamon/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"},{"name":"Richard Casaburi","slug":"richard-casaburi","institution":"University of California, Los Angeles","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/richard-casaburi","json_url":"https://www.findmykol.com/kol/richard-casaburi/profile.json"},{"name":"Jerome Engel","slug":"jerome-engel","institution":"University of California, Los Angeles","specialty":"Neurology","url":"https://www.findmykol.com/kol/jerome-engel","json_url":"https://www.findmykol.com/kol/jerome-engel/profile.json"},{"name":"Baha Sibai","slug":"baha-sibai","institution":"McGovern Medical School at UTHealth Houston","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/baha-sibai","json_url":"https://www.findmykol.com/kol/baha-sibai/profile.json"},{"name":"Robert Coleman","slug":"robert-coleman","institution":"Vaniam Group","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-coleman","json_url":"https://www.findmykol.com/kol/robert-coleman/profile.json"},{"name":"Bradley Monk","slug":"bradley-monk","institution":"Florida Cancer Specialists & Research Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/bradley-monk","json_url":"https://www.findmykol.com/kol/bradley-monk/profile.json"},{"name":"Angeles Secord","slug":"angeles-secord","institution":"Duke University School of Medicine","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/angeles-secord","json_url":"https://www.findmykol.com/kol/angeles-secord/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}